SCHEMBL4872114

SCHEMBL4872114

C=CCCOc1ccc(-c2ccc(-c3ccc(OCCCCCCCC)cc3)cc2)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 3/20 0.42
CNR2 P34972 2/20 0.41
NR5A1 Q13285 1/20 0.40
PTPN11 Q06124 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CNR1 P21554 1/20 0.39
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
HTR1B P28222 1/20 0.38
HTR2B P41595 1/20 0.38
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868001 1.00 RARB (0.42) RARBCNR2NR5A1PTPN11CYP3A4
SCHEMBL4866798 0.99 CNR2 (0.42) RARBCNR2NR5A1PTPN11CYP3A4
SCHEMBL4862301 0.99 CNR2 (0.42) RARBCNR2NR5A1PTPN11CYP3A4
SCHEMBL4872821 0.93 NR5A1 (0.45) RARBNR5A1PTPN11CYP3A4CYP2D6
SCHEMBL9563688 0.90 RARB (0.50) RARBNR5A1PTPN11CYP3A4CYP2D6
SCHEMBL9563867 0.90 RARB (0.50) RARBNR5A1PTPN11CYP3A4CYP2D6
SCHEMBL9563757 0.90 RARB (0.50) RARBNR5A1PTPN11CYP3A4CYP2D6
SCHEMBL9493646 0.90 RARB (0.50) RARBNR5A1PTPN11CYP3A4CYP2D6
SCHEMBL9563813 0.90 RARB (0.50) RARBNR5A1PTPN11CYP3A4CYP2D6
SCHEMBL9563685 0.90 RARB (0.50) RARBNR5A1PTPN11CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351452-B2 Liquid crystalline compounds containing a biphenyl core QINETIQ LIMITED (GB) 2008-04-01 US disclosed
US-20050001200-A1 Liquid crystalline compounds containing a biphenyl core QINETIQ LIMITED (GB) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050001200-A1 Liquid crystalline compounds containing a biphenyl core YBX1, AFF1, AFF2 RARB 1075/4885CNR2 513/4885NR5A1 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.